Pneumococcal Vaccine Schedules (PVS)
Phase 4
- Conditions
- Streptococcus pneumoniae disease and pneumococcal colonisationInfections and InfestationsStreptococcus pneumoniae infection
- Registration Number
- ISRCTN15056916
- Lead Sponsor
- ondon School of Hygiene & Tropical Medicine
- Brief Summary
2022 Protocol article in https://doi.org/10.1186/s13063-021-05964-5 (added 24/05/2022)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 50000
Inclusion Criteria
1. Resident in the study area
2. Children aged 6 weeks to 365 days will be eligible to receive the intervention
3. Children aged 2 weeks to 59 months will be eligible for measurement of the primary endpoint and disease endpoints by disease surveillance
Exclusion Criteria
1. Intent to move out of the study area before 4 months of age
2. Aged over 364 days
3. Contraindication to vaccination with PCV13, including severe hypersensitivity to a previous dose of PCV13
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method